WearOptimo, a Brisbane heath technology company commercialising sticker-like sensors for monitoring biosignals, has announced its Advisory Board, made up of experts in biotechnology, healthcare, regulatory affairs, and venture investment. In a statement on Tuesday, the company said the six-member board was part of ambitions around its “Microwearable” hydration sensors and United States launch. The initial…
Brisbane-based biotechnology company Vaxxas published new research on Wednesday showing promising results for its needle-free vaccine delivery technology. The company’s high-density microarray patch (HD-MAP) – a small patch containing thousands of tiny projections coated with vaccine – successfully delivered a DNA-based COVID-19 vaccine in animal testing, according to research published in the science journal Heliyon.…
Brisbane biotechnology company Vaxxas has completed enrolment for testing a needle-free vaccine patch against avian influenza.
Clinical stage biotechnology company Vaxxas, which is commercialising a needle-free vaccine delivery platform, has added three new expert advisors to its product development and strategy team. In a statement on Thursday morning (Australian time), the company said Dr Emilio Emini, Dr Nathalie Garcon, and Professor Paul Young will join Vaxxas as consultants to provide regulatory…
The Coalition for Epidemic Preparedness Innovations (CEPI) has approved progression of a $US 4.8 million ($7.2 million) program involving Vaxxas — a Brisbane-based, clinical-stage company developing a needle vaccine delivery platform — and an mRNA Japanese encephalitis vaccine (JEV) from SK bioscience. According to a statement from Vaxxas on Thursday, the program is to develop…
Element 25’s manganese gets $US 166 million grant ASX-listed minerals company Element 25 has announced that a grant agreement has been signed for $US 166 million ($268 million) in funding from the U.S. Department of Energy (DoE) under the Battery Materials Processing Grant Program. The funding will support construction of a proposed battery-grade high-purity manganese…
This week in our Australia’s 50 Most Innovative Manufacturers series, we hear from Professor Mark Kendall, CEO and founder of WearOptimo. Brent Balinski spoke to Kendall, whose patents have generated an estimated $2 billion in economic activity. With a novel way to monitor biosignals using electrodes sitting just under a wearer’s skin, WearOptimo hopes to…
Optiscan Imaging advances veterinary medtech Confocal microscopy manufacturer Optiscan Imaging has signed a Collaborative Research Agreement with the University of Minnesota College of Veterinary Medicine. The agreement follows a MOU with the university, and is a step in expanding the clinical applications of Optiscan’s confocal endomicroscope imaging system in veterinary medicine. The initial focus of…
Needle free biotechnology company Vaxxas has announced that the United States National Institutes of Health (NIH) has granted the company a licence to a vaccine antigen candidate (DS2), designed for use in prophylactic vaccines against Respiratory Syncytial Virus (RSV). RSV is a common contagious virus affecting the lungs and breathing passages which causes an estimated…
What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Australian government, Hanwha sign IFV contract The federal government has signed contracts with Hanwha Defense Australia for 129 locally built Redback infantry fighting vehicles, to be built in Geelong for the Australian Army. Hanwha was announced as…